BioSpace News Archive

The biopharmaceutical contract manufacturing market will reach $6.3 billion this year, a 12% increase from prior year.

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced the launch of the first testing method to simultaneously detect COVID-19, influenza A / B, and respiratory syncytial virus.

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present virtually at the Morgan Stanley 18th Annual Global Healthcare Conference, held on September 14-18, 2020.

OpGen, Inc., announced that its subsidiary Ares Genetics GmbH has been nominated for the 40th Austrian Innovation Award.

Data highlights socio-demographic and clinical disparities to help raise awareness of health inequities and inform future treatment planning

Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, announced that enrollment and dosing in its Phase 1/2 clinical trial for MRT5005 in cystic fibrosis has resumed, with multiple clinical sites being open for enrollment.

Revolution Medicines, Inc., a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers, announced that the company will participate in the upcoming 2nd Annual RAS-Targeted Drug Development Conference being held virtually September 14-16, 2020.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in two upcoming virtual investor conference

Parkinson’s Disease R&D Day to be hosted by Gavin Corcoran, MD, Chief R&D Officer, on October 30th, 2020, with leading movement disorder specialists

BetterLife Pharma Inc. is pleased to announce that it has retained Hybrid Financial Ltd. to provide marketing services to the Company.